PRIORITY-CONNECT 2 Pilot Trial
Launched by SURGICAL OUTCOMES RESEARCH CENTRE (SOURCE) · Jan 8, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The PRIORITY-CONNECT 2 Pilot Trial is studying a new way to support patients with gastrointestinal cancers, such as liver, pancreas, oesophageal, gastric, and colorectal cancers, before and after their surgeries. The trial is testing a virtual program that includes exercise, nutrition, and psychological support, which has been shown to help reduce complications after surgery and shorten hospital stays. The main goals are to see if patients, their families, and doctors find this virtual program helpful and easy to use, and to gather information on how it affects recovery and quality of life.
To participate in this trial, you need to be an adult aged 18 or older who is scheduled for major gastrointestinal surgery with the intention of curing cancer. You should be able to communicate and understand the process, and have access to a device like a smartphone or computer with internet. If you join, you may be assigned to either the virtual program or standard care, and you can expect regular check-ins to monitor your progress and experiences. This trial is currently recruiting participants, and your involvement could help shape future treatments for patients facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged ≥18 years undergoing major gastrointestinal elective surgery, including liver, pancreas, oesophagus, gastric and colorectal cancer resections with curative intent
- • Consulting with a gastrointestinal cancer surgeon at least 1 week prior to scheduled surgery
- Exclusion Criteria:
- • Cognitive impairment such that they are unable to provide informed consent
- • No access to a smart device (including mobile phone, tablet, laptop or desk computer with camera) or no internet connection
About Surgical Outcomes Research Centre (Source)
The Surgical Outcomes Research Centre (SOURCE) is a leading clinical trial sponsor dedicated to advancing the field of surgical medicine through rigorous research and innovative methodologies. Committed to enhancing patient care and surgical outcomes, SOURCE collaborates with healthcare professionals, institutions, and industry partners to conduct high-quality clinical trials. By focusing on evidence-based practices and the integration of cutting-edge technologies, SOURCE aims to improve surgical techniques, patient safety, and overall healthcare delivery. Their mission is to foster a culture of collaboration and excellence in surgical research, ultimately contributing to improved patient outcomes and the advancement of surgical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sydney, New South Wales, Australia
Sydney, New South Wales, Australia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported